Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Idiopathic Pulmonary Fibrosis: early-phase trial registry
22 of 52 indexed Idiopathic Pulmonary Fibrosis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #271 of 28,707 conditions by registered trial count.
52 US clinical trials · 22 currently recruiting · #271 of 28,707 conditions by registered trial count
Idiopathic Pulmonary Fibrosis: 52 US clinical trials tracked, 22 recruiting.
Idiopathic Pulmonary Fibrosis is the subject of 52 registered US clinical trials on ClinicalTrials.gov, 22 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 33 in Phase 1-2 (earlier-stage). The most active sponsor is Boehringer Ingelheim, running 5 of these trials.
Enrollment posture brief
Registry condition idiopathic-pulmonary-fibrosis
OPEN 22 | RECR 42% | LATE 5 | EARLY 33 | RANK #271 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Metastatic Pancreatic Cancer (42% recruiting · 33 trials)
Idiopathic Pulmonary Fibrosis lists 22 open slots (42% of 52 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Idiopathic Pulmonary Fibrosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Idiopathic Pulmonary Fibrosis is recruiting above its size-band peers.
22 of 52 indexed trials (42.3%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Idiopathic Pulmonary Fibrosis trials is spread across many organizations.
Boehringer Ingelheim accounts for 5 of 52 trials (9.6%). 37 distinct sponsors appear on at least one study for this condition label.
-
Typical Idiopathic Pulmonary Fibrosis enrolment sits around 61 participants.
Median target enrolment is 61 among the 52 trials that report a genuine target (sentinel values excluded). 31 of those (59.6%) plan for fewer than 100 participants.
-
Idiopathic Pulmonary Fibrosis research is mostly interventional.
41 interventional and 11 observational studies make up this index (78.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
52 total, page 2 of 2
Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary Fibrosis
MediciNova
NCT02503657
Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/
Pliant Therapeutics
NCT04072315
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 13 |
| Phase 2 | 20 |
| Phase 3 | 4 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Idiopathic Pulmonary Fibrosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Idiopathic Pulmonary Fibrosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Idiopathic Pulmonary Fibrosis page
52 registered trials, 22 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 22 Idiopathic Pulmonary Fibrosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Boehringer Ingelheim sponsors the most Idiopathic Pulmonary Fibrosis trials on record, review their full trial history before evaluating a specific study. See Boehringer Ingelheim's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Idiopathic Pulmonary Fibrosis condition card totals 52 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.